• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾上腺素作为感染性休克的正性肌力药物:剂量-效应分析

Epinephrine as an inotropic agent in septic shock: a dose-profile analysis.

作者信息

Moran J L, O'Fathartaigh M S, Peisach A R, Chapman M J, Leppard P

机构信息

Queen Elizabeth Hospital, Woodville, South Australia.

出版信息

Crit Care Med. 1993 Jan;21(1):70-7. doi: 10.1097/00003246-199301000-00015.

DOI:10.1097/00003246-199301000-00015
PMID:8420733
Abstract

OBJECTIVE

To characterize the acute actions and physiologic dose profile of epinephrine, as a single inotrope, in patients with septic shock.

DESIGN

Prospective clinical study. The relationship between epinephrine dose and cardiovascular variables was analyzed using repeated-measures analysis of variance.

SETTING

ICU in a university teaching hospital.

PATIENTS

Eighteen patients with septic shock, mean age 64 +/- 8 (SD) yrs, and with a mean admission Acute Physiology and Chronic Health Evaluation (APACHE II) score of 23 (range 14 to 35).

INTERVENTIONS

Initial volume loading and the measurement of a baseline hemodynamic profile were followed by the administration of an epinephrine infusion at 3 microgram/min with subsequent increments of 3 micrograms/min and the determination of a hemodynamic profile after each dose increment. Therapy was titrated to clinical goals of perfusion and restoration of premorbid systolic arterial BP.

MEASUREMENTS AND MAIN RESULTS

After volume loading, mean hemodynamic indices were as follows: mean arterial pressure (MAP) 62 +/- 7 mm Hg; cardiac index 3.8 +/- 1.1 L/min/m2; left ventricular stroke work index 25 +/- 11 g.m/m2; oxygen delivery (Do2) index 460 +/- 168 mL/min/m2; and oxygen consumption (VO2) index 165 +/- 64 mL/min/m2. In the dose range of 3 to 18 microgram/min, epinephrine produced linear increases in average heart rate, MAP, cardiac index, left ventricular stroke work index, stroke volume index, VO2, and DO2. No effect was noted on pulmonary artery occlusion pressure (PAOP), mean pulmonary arterial pressure, or systemic vascular resistance index.

CONCLUSIONS

Epinephrine increases DO2 in septic shock by increasing cardiac index without an effect on systemic vascular resistance index or PAOP.

摘要

目的

明确肾上腺素作为单一正性肌力药物在感染性休克患者中的急性作用及生理剂量分布。

设计

前瞻性临床研究。采用重复测量方差分析肾上腺素剂量与心血管变量之间的关系。

地点

大学教学医院的重症监护病房。

患者

18例感染性休克患者,平均年龄64±8(标准差)岁,平均入院急性生理与慢性健康状况评分(APACHE II)为23分(范围14至35分)。

干预措施

初始容量负荷及测量基线血流动力学指标后,以3微克/分钟的速度静脉输注肾上腺素,随后每次递增3微克/分钟,并在每次剂量递增后测定血流动力学指标。治疗根据灌注及恢复病前收缩动脉血压的临床目标进行调整。

测量指标及主要结果

容量负荷后,平均血流动力学指标如下:平均动脉压(MAP)62±7毫米汞柱;心脏指数3.8±1.1升/分钟/平方米;左心室每搏功指数25±11克·米/平方米;氧输送(Do2)指数460±168毫升/分钟/平方米;氧消耗(VO2)指数165±64毫升/分钟/平方米。在3至18微克/分钟的剂量范围内,肾上腺素使平均心率、MAP、心脏指数、左心室每搏功指数、每搏量指数、VO2和Do2呈线性增加。未观察到对肺动脉闭塞压(PAOP)、平均肺动脉压或全身血管阻力指数有影响。

结论

肾上腺素通过增加心脏指数提高感染性休克患者的Do2,而对全身血管阻力指数或PAOP无影响。

相似文献

1
Epinephrine as an inotropic agent in septic shock: a dose-profile analysis.肾上腺素作为感染性休克的正性肌力药物:剂量-效应分析
Crit Care Med. 1993 Jan;21(1):70-7. doi: 10.1097/00003246-199301000-00015.
2
Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study.静脉注射乳酸米力农对小儿感染性休克患者的血流动力学影响。一项前瞻性、双盲、随机、安慰剂对照的干预性研究。
Chest. 1996 May;109(5):1302-12. doi: 10.1378/chest.109.5.1302.
3
Effects of epinephrine on right ventricular function in patients with severe septic shock and right ventricular failure: a preliminary descriptive study.肾上腺素对重症感染性休克合并右心室衰竭患者右心室功能的影响:一项初步描述性研究。
Intensive Care Med. 1997 Jun;23(6):664-70. doi: 10.1007/s001340050391.
4
Oxygen transport patterns in patients with sepsis syndrome or septic shock: influence of treatment and relationship to outcome.脓毒症综合征或感染性休克患者的氧转运模式:治疗的影响及其与预后的关系。
Crit Care Med. 1997 Jun;25(6):926-36. doi: 10.1097/00003246-199706000-00007.
5
Dobutamine improves the adequacy of gastric mucosal perfusion in epinephrine-treated septic shock.多巴酚丁胺可改善肾上腺素治疗的感染性休克患者胃黏膜灌注的充分性。
Crit Care Med. 1997 Oct;25(10):1649-54. doi: 10.1097/00003246-199710000-00013.
6
Effects of norepinephrine plus dobutamine or norepinephrine alone on left ventricular performance of septic shock patients.去甲肾上腺素联合多巴酚丁胺或单独使用去甲肾上腺素对感染性休克患者左心室功能的影响。
Crit Care Med. 1999 Sep;27(9):1708-13. doi: 10.1097/00003246-199909000-00002.
7
Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study.去甲肾上腺素和多巴酚丁胺与肾上腺素用于感染性休克血流动力学、乳酸代谢及胃张力测定变量的比较:一项前瞻性随机研究。
Intensive Care Med. 1997 Mar;23(3):282-7. doi: 10.1007/s001340050329.
8
N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock.N-乙酰-L-半胱氨酸会降低感染性休克患者的心脏功能。
Crit Care Med. 1996 Aug;24(8):1302-10. doi: 10.1097/00003246-199608000-00006.
9
Experience with phenylephrine as a component of the pharmacologic support of septic shock.
Crit Care Med. 1991 Nov;19(11):1395-400. doi: 10.1097/00003246-199111000-00016.
10
Heterogeneity and prediction of hemodynamic responses to dobutamine in patients with septic shock.脓毒性休克患者对多巴酚丁胺血流动力学反应的异质性与预测
Crit Care Med. 2006 Sep;34(9):2392-8. doi: 10.1097/01.CCM.0000233871.52553.CD.

引用本文的文献

1
[S3 guideline on sepsis-prevention, diagnosis, therapy, and follow-up care-update 2025].[S3 脓毒症预防、诊断、治疗及随访指南 - 2025年更新版]
Med Klin Intensivmed Notfmed. 2025 Aug 18. doi: 10.1007/s00063-025-01317-1.
2
Bioactive Adrenomedullin in Dogs with Sepsis and Septic Shock: A Prospective, Case-Control Study.脓毒症和脓毒性休克犬体内的生物活性肾上腺髓质素:一项前瞻性病例对照研究。
Animals (Basel). 2024 Oct 23;14(21):3054. doi: 10.3390/ani14213054.
3
Hotspot Analysis of Sepsis Literature.脓毒症文献的热点分析。
Med Sci Monit. 2018 Aug 5;24:5427-5436. doi: 10.12659/MSM.908950.
4
The Surviving Sepsis Campaign Bundle: 2018 update.拯救脓毒症运动集束化治疗方案:2018年更新版
Intensive Care Med. 2018 Jun;44(6):925-928. doi: 10.1007/s00134-018-5085-0. Epub 2018 Apr 19.
5
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.拯救脓毒症运动:脓毒症和脓毒性休克管理国际指南:2016 年版。
Intensive Care Med. 2017 Mar;43(3):304-377. doi: 10.1007/s00134-017-4683-6. Epub 2017 Jan 18.
6
Effects of dexmedetomidine and esmolol on systemic hemodynamics and exogenous lactate clearance in early experimental septic shock.右美托咪定和艾司洛尔对早期实验性脓毒症休克患者全身血流动力学及外源性乳酸清除率的影响
Crit Care. 2016 Aug 2;20(1):234. doi: 10.1186/s13054-016-1419-x.
7
Pharmacokinetics, hemodynamic and metabolic effects of epinephrine to prevent post-operative low cardiac output syndrome in children.肾上腺素预防儿童术后低心排血量综合征的药代动力学、血流动力学及代谢效应
Crit Care. 2014 Jan 24;18(1):R23. doi: 10.1186/cc13707.
8
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.拯救脓毒症运动:严重脓毒症和脓毒性休克管理国际指南,2012 年。
Intensive Care Med. 2013 Feb;39(2):165-228. doi: 10.1007/s00134-012-2769-8. Epub 2013 Jan 30.
9
Norepinephrine supplemented with dobutamine or epinephrine for the cardiovascular support of patients with septic shock.去甲肾上腺素联合多巴酚丁胺或肾上腺素用于感染性休克患者的心血管支持。
Indian J Crit Care Med. 2012 Apr;16(2):75-80. doi: 10.4103/0972-5229.99110.
10
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.拯救脓毒症运动:严重脓毒症和脓毒性休克管理国际指南:2008年版
Intensive Care Med. 2008 Jan;34(1):17-60. doi: 10.1007/s00134-007-0934-2. Epub 2007 Dec 4.